Latest news articles

Added 1 month ago Drug news

BD issues statement on FDA relating to paclitaxel-coated devices and long term mortality

BD (Becton, Dickinson and Company) issued the following statement related to the recent letter from FDA to health care providers...

Added 6 months ago Drug news

Positive trial data for Lutonix 014 Drug-Coated Balloon to treat narrowed or obstructed arteries below the knee. Becton Dickinson

BD (Becton, Dickinson and Company) announced the safety and efficacy data from the Lutonix Drug-Coated Balloon (DCB) IDE, level 1...

Added 1 year ago Drug news

REX 001 enters Phase III trials as a treatment for critical limb ischaemia.- Rexgenero Ltd.

Rexgenero Ltd, a clinical-stage regenerative medicine company developing advanced cell-based therapies with a focus on Critical Limb Ischemia (CLI), announces...

Search all news articles for Arterial embolism or thrombosis

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Load more


2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

In this document, the term ‘peripheral arterial diseases’ encompasses all arterial diseases other than coronary arteries and the aorta. This should be clearly distinguished from the term ‘peripheral artery disease’...

Added 1 year ago

Peripheral arterial disease: diagnosis and management

This guideline covers diagnosing and managing peripheral arterial disease (PAD) in people aged 18 and over.

Added 6 years ago

Search all guidelines for Arterial embolism or thrombosis

Journal articles

Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

Edoxaban is the fourth non-vitamin K antagonist oral anticoagulant now available for clinical use in the prevention of stroke/systemic embolism in atrial fibrillation (AF) and in the treatment of venous thromboembolism (VTE) ...

Added 1 year ago

Edoxaban: A direct oral anticoagulant.

Purpose: The pharmacology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, and place in therapy of edoxaban for prevention of stroke in patients with nonvalvular atrial fibrillation (AF) and ...

Added 1 year ago

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.

Background: We studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti-Xa agent...

Added 3 years ago

Search all journal articles for Arterial embolism or thrombosis



Accrediting body
BJC Learning
Credits available
Registration required
Subscription fee
Search all CME for Arterial embolism or thrombosis